atherogenic


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

ath·er·o·gen·e·sis

 (ăth′ər-ō-jĕn′ĭ-sĭs)
n.
Formation of atheromatous deposits, especially on the innermost layer of arterial walls.


ath′er·o·gen′ic (-jĕn′ĭk) adj.
ath′er·o·gen·i′ci·ty (-jə-nĭs′ĭ-tē) n.

atherogenic

(ˌæθərəʊˈdʒɛnɪk)
adj
(Pathology) causing atheroma
ˌatheroˈgenesis n

ath•er•o•gen•ic

(ˌæθ ə roʊˈdʒɛn ɪk)

adj.
capable of producing atheromatous plaques in arteries.
[1950–55]
References in periodicals archive ?
Therefore, this study was carried out with the aim to evaluate the effects of net energy levels using soybean oil on the lipid profile and assessing the atherogenic and thrombogenic indexes, as well as the omega 6:omega 3 ratio in adipose tissue and Longissimus dorsi muscle of pigs.
As depicted in the above table the mean values of LDL/ HDL are increasing with severity of COPD, which indicates the atherogenic risk.
Data from an analysis of the study participants' atherogenic protein levels demonstrated that subjects experienced statistically significant reductions in lipoprotein(a) Lp(a) and apolipoprotein B-100 (apo B).
It is likely that we actually deal with the same type of multiple atherogenic modifications, but differently evaluated by different methods of laboratory diagnostics (Tertov et al.
It reduces LDL-C by preventing the formation of atherogenic lipoproteins, the particles that carry cholesterol through the bloodstream.
An Iranian case control study found lower serum levels of HDL-C which is considered good cholesterol and higher serum levels of LDL-C, which is atherogenic, along with high TC levels in depressed individuals10.
Olive leaf extract improves the atherogenic lipid profile in rats fed a high cholesterol diet.
7, 8] The aim of this study was to compare the lipid profiles and new atherogenic indices among the CAD-negative and -positive diabetic dyslipidemia subjects and determine the use of atherogenic indices in the early prediction of CAD in diabetic subjects.
0001) and significantly improved other atherogenic lipid parameters without significantly raising LDL-C when compared with placebo (Figure 1).
Blood samples were taken on a weekly basis to diagnose the effects of test drug on serum Total Cholesterol (TC) LDL HDL Triglycerides (TG) and Atherogenic Index.
Atherogenic dyslipidaemia (AD), characterized by the elevation of plasma total cholesterol (TC), triglycerides (TG), TG-rich very low-density lipoproteins (VLDL), increased low-density lipoprotein cholesterol (LDL), and reduced high-density lipoproteins (HDL) contributes significantly to the excess risk of CVD (9).
it was found that the intake of rn-3 PUFAs leads to a decrease in triglycerides (TG), which is accompanied by increased levels of low density lipoprotein cholesterol (LDL-C), mainly due to slightly atherogenic low-weight fractions, and increased levels of high density lipoprotein cholesterol (HDL-C) [2, 3].